In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Neoadjuvant hormonal therapy for prostate cancer may increase the risk of death in men with coronary artery disease-induced heart failure or myocardial infarction…
Jay Alberts, PhD, Assistant Staff, Lerner Research Institute, Cleveland Clinic, gives us an overview of Parkinson’s Disease and describes study results which showed that exercise therapy had a…
Jay Alberts, PhD, Assistant Staff, Lerner Research Institute, Cleveland Clinic, discusses research findings on forced exercise for patients with Parkinson’s Disease. Summary 1. Based on research findings, Parkinson’s…
The diagnosis of prostate cancer can be a confusing and scary time for many men. Ken Burger discusses his process of learning to adapt and deal with the…
NEW YORK (Reuters Health) – Laparoscopic surgery is as efficient as open surgery for rectal cancer, according to results of a randomized trial. Dr. Juan Lujan and colleagues…
NEW YORK (Reuters Health) – Long-term, high-dose ursodeoxycholic acid (UDCA) should not be used for treatment of primary sclerosing cholangitis because of the increased risk of severe adverse…
NEW YORK (Reuters Health) – Instead of requiring surgery, a diagnosis of endometriosis can now be made with a biopsy, according two studies published this month in the…
Michael Banks, MD sits down with Oliver Fein, MD, President of Physicians for a National Health Program (PNHP), to discuss the current debate over health care reform and…
NEW YORK (Reuters Health) – The median survival of patients with peritoneal breast cancer metastasis is “surprisingly poor,” with only a small minority surviving longer than 6 months,…
NEW YORK (Reuters Health) – Because of their ability to prevent, reduce, and delay skeletal complications with multiple myeloma, bisphosphonates are an essential component of treatment for this…
